Let’s empower everyone with genetic insights, together.

Learn more about what we shared at the NSGC 40th Annual Conference and download resources below

Connect with us


Myriad needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.

Hidden Fields



Innovations in genetic testing to address healthcare disparities and improve outcomes

  • Review existing challenges to providing equitable care in genetic risk assessment
  • Learn how new research and technological innovations are making hereditary cancer testing and prenatal genetic screening more equitable across ancestries


Gwen Turner

Gwen Turner, MS

Head of Diversity, Equity, Inclusion, and Engagement | Myriad Genetics

Jennifer Klemp

Jennifer Klemp, PhD, MPH, MA

Professor & Director, Cancer Survivorship | University of Kansas Medical Center

Leighann Dacanay

Leighann Dacanay, MS, LCGC

Prenatal Genetic Counselor | Northwestern Medicine

allele-specific RNA analysis in hereditary cancer

The power of allele-specific RNA analysis in hereditary cancer

  • Describe two techniques for RNA analysis in hereditary cancer testing
  • Name the main utility of RNA analysis in hereditary cancer testing

Date: September 26, 2021

Time: 8:00-8:45 a.m. CT

TJ Slavin


Chief Medical Officer | Myriad Genetics

Paola Nix, PhD

Paola Nix, PhD

RNA Lab Director | Myriad Genetics


Can expanded carrier screening shorten the diagnostic odyssey in those with genetic disease?

Presenter: Maysen Mesaros, MS, CGC | Certified Genetic Counselor, Division of Neuroscience, MUSC Health

Date: September 23, 2021

Time: 8:15–9:00 a.m. CT

Download attachment

A noninvasive prenatal screen that achieves 4% fetal fraction in >99.9% of patients

Presenter: Rotem Ben-Shachar, PhD | Senior Director, Computational Science and Data Management, Clinical Development | Myriad Genetics, Inc.

Download attachment


Help patients get ahead of cancer with our hereditary cancer test. View MyRisk gene panel table.

Identify couples at risk to pass down serious, prevalent, clinically-actionable inherited conditions.

Get reliable results the first time with noninvasive prenatal screening.


Myriad Genetics is committed to expanding health equity and supporting patients, healthcare providers, and genetic counselors.

Learn more about:

  • MyRisk™ re-testing at no cost for qualifying patients across ancestries
  • Social responsibility programs, including financial assistance for patients in need
  • Support for, and creation of, genetic counseling programs at Historically Black Colleges and Universities – see news below



Our mission and purpose at Myriad Genetics is to advance health and well-being for all, empowering every individual by revealing the answers inside each of us. It is more relevant than ever, and we are committed to fulfilling it – working together to uncover new opportunities, make health more precise and personal, and push the frontiers of what’s possible.

Open to career opportunities? Join our team.

Follow us for news from NSGC